Figure 1.
Patients with breast cancer and healthy female individuals have a similar distribution of HLA-DR-positive monocytes. Flow cytometry analysis of CD14+16-HLA-DR+ (A), CD14+16+HLA-DR+ (B), and CD14low16+HLA-DR+ (C). Patients with breast cancer n = 38; healthy female individuals n = 17. Statistical analysis was performed by the Wilcoxon test.